I think discussions will get serious after the next read out, but I suspect Jon wouldn't want to formalise anything until we've got the results of all 4 trials. (Given the overall confidence and to maximise value). What do you think? Otherwise, the other way to think about it is if there's a deal done with 2 read outs, (within the next month or two) it minimises some of the risk, whilst giving an accelerated path to get trials underway by getting more funding earlier. Given our cash balance, we're already preparing for P3 for PMS but doing this for 3 other indications would be a challenge on our own.
Share Price, page-9872
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.42 |
Change
-0.540(2.58%) |
Mkt cap ! $2.619B | |||
| Open | High | Low | Value | Volume |
| $21.00 | $21.21 | $20.31 | $9.875M | 479.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29 | $20.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.43 | 302 | 8 |
View Market Depth
| Last trade - 14.26pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.45 |
Change
-0.540 ( 2.90 %) |
||||
| Open | High | Low | Volume | ||
| $20.97 | $21.15 | $20.32 | 141104 | ||
| Last updated 14.45pm 30/05/2024 ? | |||||
| NEU (ASX) Chart |